Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 224


Computational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and Cancer.

Zhao C, Popel AS.

PLoS Comput Biol. 2015 Nov 20;11(11):e1004612. doi: 10.1371/journal.pcbi.1004612. eCollection 2015 Nov.


Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.

Chu LH, Annex BH, Popel AS.

Front Pharmacol. 2015 Aug 25;6:179. doi: 10.3389/fphar.2015.00179. eCollection 2015.


Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes.

Fertig EJ, Lee E, Pandey NB, Popel AS.

Sci Rep. 2015 Jul 15;5:12133. doi: 10.1038/srep12133.


Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer.

Norton KA, Popel AS, Pandey NB.

Am J Cancer Res. 2015 Mar 15;5(4):1295-307. eCollection 2015.


PADPIN: protein-protein interaction networks of angiogenesis, arteriogenesis, and inflammation in peripheral arterial disease.

Chu LH, Vijay CG, Annex BH, Bader JS, Popel AS.

Physiol Genomics. 2015 Aug;47(8):331-43. doi: 10.1152/physiolgenomics.00125.2014. Epub 2015 Jun 9.


Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Lee E, Pandey NB, Popel AS.

Expert Rev Mol Med. 2015 Jan 30;17:e3. doi: 10.1017/erm.2015.2. Review.


Inhibition of breast cancer growth and metastasis by a biomimetic peptide.

Lee E, Lee SJ, Koskimaki JE, Han Z, Pandey NB, Popel AS.

Sci Rep. 2014 Nov 20;4:7139. doi: 10.1038/srep07139.


Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model.

Kim E, Lee E, Plummer C, Gil S, Popel AS, Pathak AP.

Angiogenesis. 2015 Apr;18(2):125-36. doi: 10.1007/s10456-014-9450-5. Epub 2014 Nov 19.


A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.

Rosca EV, Penet MF, Mori N, Koskimaki JE, Lee E, Pandey NB, Bhujwalla ZM, Popel AS.

PLoS One. 2014 Nov 10;9(11):e111901. doi: 10.1371/journal.pone.0111901. eCollection 2014.


Angiogenesis interactome and time course microarray data reveal the distinct activation patterns in endothelial cells.

Chu LH, Lee E, Bader JS, Popel AS.

PLoS One. 2014 Oct 16;9(10):e110871. doi: 10.1371/journal.pone.0110871. eCollection 2014.


Computational systems biology approaches to anti-angiogenic cancer therapeutics.

Finley SD, Chu LH, Popel AS.

Drug Discov Today. 2015 Feb;20(2):187-97. doi: 10.1016/j.drudis.2014.09.026. Epub 2014 Oct 5. Review.


Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells.

Norton KA, Han Z, Popel AS, Pandey NB.

Onco Targets Ther. 2014 Sep 9;7:1571-82. doi: 10.2147/OTT.S65055. eCollection 2014.


An agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and location.

Norton KA, Popel AS.

J R Soc Interface. 2014 Nov 6;11(100):20140640. doi: 10.1098/rsif.2014.0640.


Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis.

Lee E, Fertig EJ, Jin K, Sukumar S, Pandey NB, Popel AS.

Nat Commun. 2014 Sep 2;5:4715. doi: 10.1038/ncomms5715.


Lymphatic endothelial cells support tumor growth in breast cancer.

Lee E, Pandey NB, Popel AS.

Sci Rep. 2014 Jul 28;4:5853. doi: 10.1038/srep05853.


Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts.

Imoukhuede PI, Popel AS.

Cancer Med. 2014 Apr;3(2):225-44. doi: 10.1002/cam4.188. Epub 2014 Jan 22.


A bioimage informatics based reconstruction of breast tumor microvasculature with computational blood flow predictions.

Stamatelos SK, Kim E, Pathak AP, Popel AS.

Microvasc Res. 2014 Jan;91:8-21. doi: 10.1016/j.mvr.2013.12.003. Epub 2013 Dec 14.


Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.

Vempati P, Popel AS, Mac Gabhann F.

Cytokine Growth Factor Rev. 2014 Feb;25(1):1-19. doi: 10.1016/j.cytogfr.2013.11.002. Epub 2013 Nov 27. Review.


A systems biology view of blood vessel growth and remodelling.

Logsdon EA, Finley SD, Popel AS, Mac Gabhann F.

J Cell Mol Med. 2014 Aug;18(8):1491-508. doi: 10.1111/jcmm.12164. Epub 2013 Nov 17. Review.


Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

Tan WH, Popel AS, Mac Gabhann F.

Cell Signal. 2013 Dec;25(12):2496-510. doi: 10.1016/j.cellsig.2013.08.015. Epub 2013 Aug 29.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk